MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Galena Biopharma Company Profile (NASDAQ:GALE)

Consensus Ratings for Galena Biopharma (NASDAQ:GALE) (?)
Ratings Breakdown: 1 Hold Rating(s), 7 Buy Rating(s)
Consensus Rating:Buy (Score: 2.88)
Consensus Price Target: $3.94 (127.60% upside)

Analysts' Ratings History for Galena Biopharma (NASDAQ:GALE)
Show:
DateFirmActionRatingPrice TargetActions
5/13/2016Noble FinancialReiterated RatingBuy$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/13/2016Maxim GroupReiterated RatingBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016FBR & Co.Reiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016Roth CapitalLower Price TargetBuy$6.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2016OppenheimerReiterated RatingOutperform$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/8/2015Cantor FitzgeraldUpgradeSell -> Hold$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2015Raymond JamesInitiated CoverageOutperform$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015MLV & Co.Reiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Needham & Company LLCSet Price TargetBuy$7.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha